Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Accounts Payables: 2009-2025

Historic Accounts Payables for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to $18.9 million.

  • Prestige Consumer Healthcare's Accounts Payables rose 34.49% to $41.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.9 million, marking a year-over-year increase of 34.49%. This contributed to the annual value of $18.9 million for FY2025, which is 51.45% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Accounts Payables stood at $18.9 million for FY2025, which was down 51.45% from $39.0 million recorded in FY2024.
  • In the past 5 years, Prestige Consumer Healthcare's Accounts Payables ranged from a high of $62.7 million in FY2023 and a low of $18.9 million during FY2025.
  • Over the past 3 years, Prestige Consumer Healthcare's median Accounts Payables value was $39.0 million (recorded in 2024), while the average stood at $40.2 million.
  • In the last 5 years, Prestige Consumer Healthcare's Accounts Payables climbed by 21.28% in 2022 and then tumbled by 51.45% in 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Accounts Payables (Yearly) stood at $46.0 million in 2021, then grew by 21.28% to $55.8 million in 2022, then rose by 12.52% to $62.7 million in 2023, then plummeted by 37.88% to $39.0 million in 2024, then tumbled by 51.45% to $18.9 million in 2025.